Infectious Disease & Vaccines

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

In the 21^st century, viral spillovers will become more and more common. We are not in the dark and can prepare now for new breakouts before they even begin.

Noncoding RNA molecules are involved in key cellular processes affecting neurodevelopment and immunity.

New inhibitors specific for gonorrhea enzymes may pave the way to treating multi-drug resistant infections.

Plants offer several unique advantages for accelerated vaccine production.

Scientists identified two proteins that help Lyme bacteria evade detection by the human complement system, paving the way for new therapeutics and vaccine targets.

A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.

CRISPR biosensing technology provides unambiguous pathogen detection.

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.

Using comedy to talk about technical topics makes science more accessible.

What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?

Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.